1 year return (CAGR)
-50.98%
NervGen Pharma Corp. Exchange (NASDAQ, USD)
NGEN
1.48
-0.04 (-2.60%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
5.26%
5 year return (CAGR)
-4.82%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
161.28M
Price/Sales
-
Ent value
147.39M
Price/Book
9.32
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
17.41%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.54 |
| Daily high | 1.55 |
| Daily low | 1.50 |
| Daily Volume | 293K |
| All-time high | 5.97 |
| 1y analyst estimate | 10.00 |
| Beta | 0.73 |
| EPS (TTM) | -0.73 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NGEN | S&P500 | |
| Current price drop from All-time high | -75.21% | -1.21% |
| Highest price drop | -74.87% | -56.47% |
| Date of highest drop | 21 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -36.32% | -10.65% |
| Avg time to new high | 63 days | 12 days |
| Max time to new high | 556 days | 1805 days |
News
